Literature DB >> 33544733

Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.

Ko Ko1, Shintaro Nagashima1, Bunthen E1,2, Serge Ouoba1,3, Tomoyuki Akita1, Aya Sugiyama1, Masayuki Ohisa1, Takemasa Sakaguchi4, Hidetoshi Tahara5, Hiroki Ohge6, Hideki Ohdan7, Tatsuhiko Kubo8, Eisaku Kishita9, Masao Kuwabara10, Kazuaki Takahashi1, Junko Tanaka1.   

Abstract

BACKGROUND: In this study, we performed molecular characterization of SARS-CoV-2 strains in Hiroshima and its mutation pattern between the first and second waves of the outbreak.
METHOD: A total of 55 nasal swab samples from the first wave in Hiroshima and 13 from the second wave were examined quantitatively by RT-qPCR and qualitatively by nested PCR using specific primers. Four samples from each wave underwent next-generation sequencing and phylogenetic tree analysis including controls and all sequences retrieved in Japan from GISAID and GenBank. Subsequently, mutations were examined.
RESULTS: Viral load ranged 7.85 × 101-1.42 × 108 copies/ml. Of 68 samples, one was Asian type-O, 65 were European type-GR, and 2 were undetectable. Phylogenetic tree analysis indicated that Japan was infected with various Asian strains (L, S, V, O) from January through April. By second week of March, European strains (G, GH, GR) had appeared, and GR strains became predominant after mid-March. The first case in Hiroshima was classified as Asian strain O, and the rest were GR strains. Then, second wave of GR strains appeared independently with 11-15 base mutations. Comparing the first- and second-wave GR strains, mutation rate was 1.17-1.36 × 10-3 base substitutions per site per year; in addition, amino acid changes occurred at S1361P and P3371S in ORF1a, A314V in ORF1b, and P151L in N. All seven GR strains were D614G variants with R202K and G203R mutations in N. A single-nucleotide insertion in ORF8 that causes a defect in ORF8 protein was found in one isolate (S66) from the second wave.
CONCLUSION: Our findings reveal the evolutionary hierarchy of SARS-CoV-2 in Japan. The predominant D614G variants and a new form of ORF8 deletion in Hiroshima provide the clue for role of viral factor in local outbreaks of SARS-CoV-2.

Entities:  

Mesh:

Year:  2021        PMID: 33544733      PMCID: PMC7864667          DOI: 10.1371/journal.pone.0246383

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  22 in total

1.  Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis.

Authors:  Marco Salemi; Walter M Fitch; Massimo Ciccozzi; Maria Jose Ruiz-Alvarez; Giovanni Rezza; Martha J Lewis
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.

Authors:  Holger A Lindner; Nasser Fotouhi-Ardakani; Viktoria Lytvyn; Paule Lachance; Traian Sulea; Robert Ménard
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Cytokines: The Good, the Bad, and the Deadly.

Authors:  Thulasi Ramani; Carol S Auletta; Daniel Weinstock; Barbara Mounho-Zamora; Patricia C Ryan; Theodora W Salcedo; Gregory Bannish
Journal:  Int J Toxicol       Date:  2015-05-26       Impact factor: 2.032

Review 4.  Mechanisms of coronavirus cell entry mediated by the viral spike protein.

Authors:  Sandrine Belouzard; Jean K Millet; Beth N Licitra; Gary R Whittaker
Journal:  Viruses       Date:  2012-06-20       Impact factor: 5.048

5.  Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia.

Authors:  Chikako Yamamoto; Shintaro Nagashima; Channarena Chuon; Ko Ko; Son Huy Do; Oline Lim; Sirany Hok; Somana Svay; Junko Matsuo; Keiko Katayama; Kazuaki Takahashi; Junko Tanaka
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

6.  Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.

Authors:  Maria Pachetti; Bruna Marini; Francesca Benedetti; Fabiola Giudici; Elisabetta Mauro; Paola Storici; Claudio Masciovecchio; Silvia Angeletti; Massimo Ciccozzi; Robert C Gallo; Davide Zella; Rudy Ippodrino
Journal:  J Transl Med       Date:  2020-04-22       Impact factor: 5.531

Review 7.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

8.  Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

Authors:  Wanbo Tai; Lei He; Xiujuan Zhang; Jing Pu; Denis Voronin; Shibo Jiang; Yusen Zhou; Lanying Du
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 11.530

9.  SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.

Authors:  Yujiro Toyoshima; Kensaku Nemoto; Saki Matsumoto; Yusuke Nakamura; Kazuma Kiyotani
Journal:  J Hum Genet       Date:  2020-07-22       Impact factor: 3.172

10.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

View more
  13 in total

1.  Whole-genome analysis and mutation pattern of SARS-CoV-2 during first and second wave outbreak in Gwangju, Republic of Korea.

Authors:  Shilpa Chatterjee; Choon-Mee Kim; You Mi Lee; Jun-Won Seo; Da Young Kim; Na Ra Yun; Dong-Min Kim
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

Review 2.  Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.

Authors:  Nathan M Markarian; Gaël Galli; Dhanesh Patel; Mark Hemmings; Priya Nagpal; Albert M Berghuis; Levon Abrahamyan; Silvia M Vidal
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

3.  Human miRNAs to Identify Potential Regions of SARS-CoV-2.

Authors:  Nimisha Ghosh; Indrajit Saha; Nikhil Sharma; Jnanendra Prasad Sarkar
Journal:  ACS Omega       Date:  2022-06-07

4.  Sequential dynamics of virological and serological changes in the serum of SARS-CoV-2 infected patients.

Authors:  Serge Ouoba; Mafumi Okimoto; Shintaro Nagashima; Yoshihiro Kitahara; Kei Miwata; Ko Ko; Bunthen E; Aya Sugiyama; Kazuaki Takahashi; Takemasa Sakaguchi; Toshiro Takafuta; Junko Tanaka
Journal:  J Med Virol       Date:  2021-12-20       Impact factor: 20.693

Review 5.  One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.

Authors:  Fernando González-Candelas; Marie-Anne Shaw; Tung Phan; Urmila Kulkarni-Kale; Dimitrios Paraskevis; Fabio Luciani; Hirokazu Kimura; Manuela Sironi
Journal:  Infect Genet Evol       Date:  2021-04-26       Impact factor: 4.393

Review 6.  Hematological changes associated with COVID-19 infection.

Authors:  Enass Abdul Kareem Dagher Al-Saadi; Marwa Ali Abdulnabi
Journal:  J Clin Lab Anal       Date:  2021-11-16       Impact factor: 3.124

Review 7.  Looking for a needle in a haystack. SARS-CoV-2 variant characterization in sewage.

Authors:  Marta Itarte; Sílvia Bofill-Mas; Sandra Martínez-Puchol; Helena Torrell; Adrià Ceretó; Marina Carrasco; Eva Forés; Núria Canela; Rosina Girones; Marta Rusiñol
Journal:  Curr Opin Environ Sci Health       Date:  2021-11-06

8.  Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.

Authors:  Ko Ko; Kazuaki Takahashi; Shintaro Nagashima; Bunthen E; Serge Ouoba; Md Razeen Ashraf Hussain; Tomoyuki Akita; Aya Sugiyama; Takemasa Sakaguchi; Hidetoshi Tahara; Hiroki Ohge; Hideki Ohdan; Tatsuhiko Kubo; Nobuhisa Ishikawa; Toshiro Takafuta; Yoshiki Fujii; Michi Mimori; Fumie Okada; Eisaku Kishita; Kunie Ariyoshi; Masao Kuwabara; Junko Tanaka
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

9.  Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima.

Authors:  Ko Ko; Kazuaki Takahashi; Shintaro Nagashima; Bunthen E; Serge Ouoba; Toshiro Takafuta; Yoshiki Fujii; Michi Mimori; Fumie Okada; Eisaku Kishita; Kunie Ariyoshi; Md Razeen Ashraf Hussain; Aya Sugiyama; Tomoyuki Akita; Masao Kuwabara; Junko Tanaka
Journal:  Viruses       Date:  2022-03-30       Impact factor: 5.048

10.  Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study.

Authors:  Terry Lee; Matthew P Cheng; Donald C Vinh; Todd C Lee; Karen C Tran; Brent W Winston; David Sweet; John H Boyd; Keith R Walley; Greg Haljan; Allison McGeer; François Lamontagne; Robert Fowler; David Maslove; Joel Singer; David M Patrick; John C Marshall; Kevin D Burns; Srinivas Murthy; Puneet K Mann; Geraldine Hernandez; Kathryn Donohoe; Genevieve Rocheleau; James A Russell
Journal:  CMAJ Open       Date:  2022-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.